BE899937A - Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.

Info

Publication number
BE899937A
BE899937A BE1/011042A BE1011042A BE899937A BE 899937 A BE899937 A BE 899937A BE 1/011042 A BE1/011042 A BE 1/011042A BE 1011042 A BE1011042 A BE 1011042A BE 899937 A BE899937 A BE 899937A
Authority
BE
Belgium
Prior art keywords
medicaments
alkyl
novel
preparation
dihydropyridine derivatives
Prior art date
Application number
BE1/011042A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE899937A publication Critical patent/BE899937A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BE1/011042A 1983-06-21 1984-06-18 Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments. BE899937A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH339483 1983-06-21

Publications (1)

Publication Number Publication Date
BE899937A true BE899937A (fr) 1984-12-18

Family

ID=4255028

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011042A BE899937A (fr) 1983-06-21 1984-06-18 Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.

Country Status (15)

Country Link
JP (1) JPS6013789A (de)
AU (1) AU2956484A (de)
BE (1) BE899937A (de)
CH (1) CH663616A5 (de)
DE (1) DE3421992A1 (de)
DK (1) DK299784A (de)
FR (1) FR2549058B1 (de)
GB (1) GB2142021B (de)
IL (1) IL72152A0 (de)
IT (1) IT1199143B (de)
LU (1) LU85423A1 (de)
NL (1) NL8401932A (de)
SE (1) SE8403268L (de)
WO (1) WO1985000169A1 (de)
ZA (1) ZA844725B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4755512A (en) * 1984-04-11 1988-07-05 Bristol-Myers Company Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities
NL8503262A (nl) * 1984-12-10 1986-07-01 Sandoz Ag 1,4-dihydropyridinederivaten, werkwijze voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.
EP0191724A3 (de) * 1985-01-15 1986-12-03 Sandoz Ag 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4659717A (en) * 1985-08-21 1987-04-21 Eli Lilly And Company Dihydropyridines useful in the treatment of angina and stroke
EP0222702A3 (de) * 1985-11-06 1988-01-07 Ciba-Geigy Ag Basische Carbonylverbindungen
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
WO1988007531A1 (en) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh New optically active compounds
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers
AU2614288A (en) * 1987-10-27 1989-05-23 Byk Gulden Lomberg Chemische Fabrik Gmbh New pyrrolidines
JPH10205466A (ja) * 1997-01-23 1998-08-04 Mitsubishi Heavy Ind Ltd スクロール型流体機械

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
JPS57175165A (en) * 1981-04-21 1982-10-28 Tokyo Tanabe Co Ltd Novel 1,4-dihydropyridine-3,5-dicarboxylic diester derivative and its salt
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP0094159B1 (de) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridinderivate, deren Herstellung und Verwendung

Also Published As

Publication number Publication date
SE8403268D0 (sv) 1984-06-19
CH663616A5 (de) 1987-12-31
GB8415523D0 (en) 1984-07-25
NL8401932A (nl) 1985-01-16
ZA844725B (en) 1986-02-26
FR2549058B1 (fr) 1988-02-19
LU85423A1 (fr) 1985-03-26
IT1199143B (it) 1988-12-30
DE3421992A1 (de) 1985-01-03
FR2549058A1 (fr) 1985-01-18
SE8403268L (sv) 1984-12-22
AU2956484A (en) 1985-01-03
DK299784D0 (da) 1984-06-19
DK299784A (da) 1984-12-22
WO1985000169A1 (en) 1985-01-17
IT8448415A0 (it) 1984-06-19
IL72152A0 (en) 1984-10-31
GB2142021A (en) 1985-01-09
JPS6013789A (ja) 1985-01-24
GB2142021B (en) 1987-07-15

Similar Documents

Publication Publication Date Title
KR870000332A (ko) 이미다조헤테로 사이클릭 화합물의 제조방법
BE901274A (fr) Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments.
DE3370478D1 (en) Isoquinolinesulfonamide derivatives and process for the preparation thereof
BE900425A (fr) Nouveaux esters et amides aromatiques, leur preparation et leur utilisation comme medicaments.
EA199800051A1 (ru) Производные бензамида и их применение в качестве антагонистов вазопрессина
KR840000494A (ko) 디하이드로피리딘의 제조방법
FI843765L (fi) Kramp motverkande sulfamatderivat.
BE899937A (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments.
ES2045152T3 (es) Derivados de lipidos, su preparacion y uso.
HUP9800087A2 (hu) Alkoxi-imino-ecetsav-amidok, e vegyületeket tartalmazó növényvédő szerek, valamint eljárás kártevők leküzdésére, továbbá e vegyületek előállítására
BE904796A (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant.
DE69031913T2 (de) Antivirale mittel
ES8301972A1 (es) Procedimiento para la obtencion de n-oxidos de compuestos den-oxaciclil-alquil-piperidil-diaza
KR910016695A (ko) 4-(아미노메틸) 피페리딘 유도체, 그의 제조방법 및 치료에의 이용
ATE73447T1 (de) Verbindung auf basis von chinolin, verfahren zur herstellung und antikrebsmittel enthaltend diese verbindung als pharmakologisch wirksame komponente.
KR860000269A (ko) 칼슘길항성의 1-[비스-(4-플루오로페닐)-메틸-4-(3-페닐-2-프로페닐)-헥사하이드로-1h-1, 4-디아제핀의 제조방법및 이것을 함유한 약학적조성물
BR9809643A (pt) Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm
KR910016689A (ko) 우레아 유도체 및 이의 염, 이를 함유하는 약제학적 조성물 및 이의 제조방법
KR870010034A (ko) 3-카바모일-4-하이드록시-쿠마린 및 이의 제조방법
FR2419935A1 (fr) Analogues de la prostaglandine i2 et compositions pharmaceutiques les contenant
DE3788149T2 (de) Prostazyklin-(PGI2)-Analoge.
FR2591599B1 (fr) Nouvelles anthracyclines et medicaments les contenant
BE905397A (fr) Nouveaux ethers allyliques bicycliques, leur preparation et leur utilisation comme anti-fongiques et fongicides.
KR910006310A (ko) 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체
BE900874A (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19880630